FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2119598337> ?p ?o ?g. }

• W2119598337 endingPage "368" @default.
• W2119598337 startingPage "358" @default.
• W2119598337 abstract "Rationale and objectives Dedicated contrast agents are now available for contrast-enhanced magnetic resonance angiography (CE-MRA). This study retrospectively compares the safety and diagnostic performance data from Phase III regulatory trials performed to evaluate gadobenate dimeglumine (MultiHance®) and gadofosveset trisodium (Vasovist®) for renal and peripheral CE-MRA. Materials and methods Similar examination and blinded assessment methodology was utilized in all studies to determine the safety and diagnostic performance of the agents for detection of significant (>50%) steno-occlusive disease. Digital Subtraction Angiography (DSA) was used as the standard of truth. Diagnostic performance data (sensitivity, specificity, predictive values [PVs], and likelihood ratios [LRs]) were compared (Chi-square test). Results CE-MRA with gadobenate dimeglumine was more specific (92.4% vs. 80.5%, p < 0.0001) and accurate (83.6% vs. 77.1%, p = 0.022) than CE-MRA with gadofosveset in the detection of significant renal artery stenosis. The average sensitivity was higher for gadofosveset (74.4% vs. 67.3%, p = 0.011) in peripheral vessels although gadobenate dimeglumine was more specific (93.0% vs. 88.2%, p < 0.0001) with no difference in accuracy (86.6% vs. 86.3%, p = 0.66). PPVs were higher (p < 0.0001) for gadobenate dimeglumine in both vascular territories. Pre- to post-test shifts in the probability of detecting significant disease were greater after gadobenate dimeglumine. Adverse events in the renal and peripheral studies were reported by 9.2% and 7.7% of patients after gadobenate dimeglumine compared with 30.3% and 22.1% of patients after gadofosveset. Conclusion The diagnostic performance of CE-MRA for the detection of significant steno-occlusive disease is similar with gadofosveset and gadobenate dimeglumine although the rate of adverse events appears higher with gadofosveset." @default.
• W2119598337 created "2016-06-24" @default.
• W2119598337 creator A5009549789 @default.
• W2119598337 creator A5011721900 @default.
• W2119598337 creator A5043342057 @default.
• W2119598337 creator A5048058243 @default.
• W2119598337 creator A5052667370 @default.
• W2119598337 creator A5055119292 @default.
• W2119598337 creator A5065517591 @default.
• W2119598337 creator A5074561197 @default.
• W2119598337 date "2011-02-01" @default.
• W2119598337 modified "2023-10-14" @default.
• W2119598337 title "Contrast-enhanced MRA of the renal and aorto-iliac-femoral arteries: Comparison of gadobenate dimeglumine and gadofosveset trisodium" @default.
• W2119598337 cites W191064394 @default.
• W2119598337 cites W1965523766 @default.
• W2119598337 cites W1967234498 @default.
• W2119598337 cites W1968309606 @default.
• W2119598337 cites W1970272296 @default.
• W2119598337 cites W1970793787 @default.
• W2119598337 cites W1972209345 @default.
• W2119598337 cites W1974139950 @default.
• W2119598337 cites W1974196454 @default.
• W2119598337 cites W1978515483 @default.
• W2119598337 cites W1978637492 @default.
• W2119598337 cites W1981822918 @default.
• W2119598337 cites W1989177243 @default.
• W2119598337 cites W1989194396 @default.
• W2119598337 cites W1989462746 @default.
• W2119598337 cites W1995384366 @default.
• W2119598337 cites W1995385086 @default.
• W2119598337 cites W1996577264 @default.
• W2119598337 cites W2001784133 @default.
• W2119598337 cites W2006063943 @default.
• W2119598337 cites W2007732981 @default.
• W2119598337 cites W2015893664 @default.
• W2119598337 cites W2018820281 @default.
• W2119598337 cites W2022234183 @default.
• W2119598337 cites W2029397794 @default.
• W2119598337 cites W2030003406 @default.
• W2119598337 cites W2030777991 @default.
• W2119598337 cites W2033595132 @default.
• W2119598337 cites W2034085527 @default.
• W2119598337 cites W2034127219 @default.
• W2119598337 cites W2036261957 @default.
• W2119598337 cites W2039458927 @default.
• W2119598337 cites W2042624772 @default.
• W2119598337 cites W2043070144 @default.
• W2119598337 cites W2043638187 @default.
• W2119598337 cites W2051209202 @default.
• W2119598337 cites W2054245580 @default.
• W2119598337 cites W2055277420 @default.
• W2119598337 cites W2057123344 @default.
• W2119598337 cites W2057545473 @default.
• W2119598337 cites W2058710711 @default.
• W2119598337 cites W2064582130 @default.
• W2119598337 cites W2070451910 @default.
• W2119598337 cites W2078131849 @default.
• W2119598337 cites W2082361994 @default.
• W2119598337 cites W2083138119 @default.
• W2119598337 cites W2084893557 @default.
• W2119598337 cites W2091614305 @default.
• W2119598337 cites W2093474936 @default.
• W2119598337 cites W2097455886 @default.
• W2119598337 cites W2106847133 @default.
• W2119598337 cites W2123926864 @default.
• W2119598337 cites W2127950476 @default.
• W2119598337 cites W2133718010 @default.
• W2119598337 cites W2136421454 @default.
• W2119598337 cites W2136437112 @default.
• W2119598337 cites W2139687894 @default.
• W2119598337 cites W2141682482 @default.
• W2119598337 cites W2142044575 @default.
• W2119598337 cites W2144420100 @default.
• W2119598337 cites W2145726460 @default.
• W2119598337 cites W2150458894 @default.
• W2119598337 cites W2150744593 @default.
• W2119598337 cites W2152739858 @default.
• W2119598337 cites W2152761292 @default.
• W2119598337 cites W2153027921 @default.
• W2119598337 cites W2155955824 @default.
• W2119598337 cites W2156678187 @default.
• W2119598337 cites W2164777277 @default.
• W2119598337 cites W2165727930 @default.
• W2119598337 cites W2165936389 @default.
• W2119598337 cites W2166916748 @default.
• W2119598337 cites W2170655241 @default.
• W2119598337 cites W2315743264 @default.
• W2119598337 cites W2318259483 @default.
• W2119598337 cites W2325902101 @default.
• W2119598337 cites W3187931493 @default.
• W2119598337 doi "https://doi.org/10.1016/j.ejrad.2009.07.020" @default.
• W2119598337 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19679417" @default.
• W2119598337 hasPublicationYear "2011" @default.
• W2119598337 type Work @default.
• W2119598337 sameAs 2119598337 @default.
• W2119598337 citedByCount "11" @default.
• W2119598337 countsByYear W21195983372013 @default.
• W2119598337 countsByYear W21195983372014 @default.

• next